018485062

DECIPHERA

---

June 3, 2021

Trademark Summary

The trademark application DECIPHERA was filed by Deciphera Pharmaceuticals, LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on June 21, 2021, and it was registered by office on September 28, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

---

Goods And Services

• The mark was filed in class 5 with Pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma.
• The mark was filed in class 42 with Pharmaceutical research and development.
• The mark was filed in class 44 with Medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma.